All News

Article

ACIP Recommendations for Pfizer Vaccine Candidate

Rachel Tate, DO Dec 07, 2020

The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.

Roundtable on Gout: What's Hot at #ACR20 with Gout Faculty https://t.co/bCFQJuagsP https://t.co/ws0yVkygYH

https://bit.ly/3mOGxBK

#BestACR20Tweets RT @RichardPAConway : Dr Baker reports on non-invasive vagal nerve stimulation to treat RA. 30 patients over 12 weeks. Mean DAS28-CRP decreased by 1.4. 53% achieved ACR20, 33% ACR50, 17% ACR70 @rheumnow #ACR20 Abstr#1995 #ACRbest https://t.co/qMOinHd3oY

Zoster Vaccine in Rheumatic Disease: Dr. David Liew ( @drdavidliew) #ACR20 https://t.co/5YrNUVMNB2 https://t.co/X6F4CeJzCH

https://bit.ly/3gkRxo4

#BestACR20Tweets RT @doctorRBC : AxSpa pts had Significant Gut Microbiome Differences in: 1⃣Disease activity and duration 2⃣Enthesitis 3⃣Radiographic involvement Abs#1853 https://t.co/ynemrgsP3W

Anakinra in Pediatric, Adult Still's Disease: Dr. Bella Mehta ( @bella_mehta) #ACR20 https://t.co/QiBEI11LY5 https://t.co/GTf7iUsfGt

https://bit.ly/3qACPOo

Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis ( @RADoctor) reviews abstract #1444 at #ACR20. https://t.co/4tqWuzwn54 https://t.co/u0vn4d1yF8

https://bit.ly/2K06IqE

#BestACR20Tweets RT @drdavidliew :The 'triple M' irAEs (myositis/myocarditis/MG): one of the rheumatic irAEs where autoAb are freq pos Nice systematic review: any autoAb+ 61% tested MG+ 59% tested MSA+ in 27% tested (18/67, 11 had myositis alone) https://t.co/aQHapPbjw9

Check out our latest. PIANO Study - Safety of Biologics in Pregnancy https://t.co/XskLByJZ9n https://t.co/JBHKo0T0jX

https://bit.ly/2JMqh5F

New podcast! Dr Jack Cush takes questions from RheumNow listeners PIANO Study - Safety of Biologics in Pregnancy Premature osteoporosis and high tryptase Mega-methotrexate doses SLE criteria and SLEDAI substitutions https://t.co/45n3KjJHqs

https://bit.ly/37DPJlW

#BestACR20Tweets RT @uptoTate : Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/vWjvAEeDMi https://t.co/HdMKSkkJ8I

https://bit.ly/2VLbHho

#BestACR20Tweets RT @RichardPAConway : Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/TR9IS9hUgu

Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20 https://t.co/ePrhQ90kwD

https://bit.ly/33Epn26

Check out our latest article from Richard Conway ( @RichardPAConway) #ACR20 The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis https://t.co/VG1ah3Nq5c https://t.co/js3l527VHg

https://bit.ly/2UvUk3G

Revisit #ACR20 through the RheumNow podcast. Day 2, Part III available now. https://t.co/rgvlZzVMkX

https://bit.ly/36fFcN1

#BestACR20Tweets RT @MeralElRamahiMD : A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI; hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20

Check out the latest from Dr. Bella Mehta ( @bella_mehta) #ACR20 Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis https://t.co/yataL7H8X4 https://t.co/xT1vCBDLyZ

https://bit.ly/3eN57iX

Revisit #ACR20 through the RheumNow podcast. Day 2, Part II available now. https://t.co/NipWyiTqtl https://t.co/kBz2jVaSLN

https://bit.ly/3mWaC1Q

#BestACR20Tweets "RT @drdavidliew : Just a reminder: inflammatory arthritis irAEs can occur at almost any time after immune checkpoint inhibitor cancer immunotherapy is commenced. @LoyolaChicago #ACR20 ABST1566 @RheumNow https://t.co/x7DLzZcn9o https://t.co/OmpTAorA13

https://bit.ly/2Vp8OTa

Dr. Ruderman ( @JointMD) discusses a new pathway - the use of deucravacitinib - to treat psoriatic arthritis at #ACR20. https://t.co/1uz47jKVPv https://t.co/1I5B14w9Ox

https://bit.ly/3qjIo3w

Topics

All News

ACIP Recommendations for Pfizer Vaccine Candidate

Do you get our email newsletter?